Inhibition of Epstein-Barr virus early antigen activation promoted by 12-O-tetradecanoylphorbol-13-acetate by the non-steroidal anti-inflammatory drugs

Cancer Letters

Volumn 161, Issue 2, 2000, Pages 221-229

  Kapadia, Govind J ^a   Azuine, Magnus A ^a,b   Takayasu, Jyunko ^c   Konoshima, Takao ^d   Takasaki, Midori ^c   Nishino, Hoyoku ^c   Tokuda, Harukuni ^c  

^a HOWARD UNIVERSITY   (United States)

^b BOWIE STATE UNIVERSITY   (United States)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^d KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Cancer; Chemoprevention; Epstei n Barr virus activation; Inhibition; Non steroidal anti inflammatory drugs; Structure activity

Indexed keywords

ACETYLSALICYLIC ACID; AMINOSALICYLIC ACID; CAPSAICIN; DICLOFENAC; DIFLUNISAL; ETODOLAC; FENOPROFEN; FLURBIPROFEN; IBUPROFEN; INDOMETACIN; KETOROLAC TROMETAMOL; MEFENAMIC ACID; MESALAZINE; NONSTEROID ANTIINFLAMMATORY AGENT; OLSALAZINE; OXAPROZIN; OXYPHENBUTAZONE; PARACETAMOL; PHENYLBUTAZONE; PHORBOL 13 ACETATE 12 MYRISTATE; PIROXICAM; SALAZOSULFAPYRIDINE; SALICIN; SALICYLIC ACID; SULINDAC; SUPROFEN; THIOSALICYLIC ACID; TOLMETIN; UNINDEXED DRUG; VIRUS ANTIGEN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER PREVENTION; CARCINOGENESIS; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; OXIDATION; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

ACETIC ACIDS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIGENS, VIRAL; BENZENE; CARCINOGENS; CARCINOMA; CELL SURVIVAL; ETODOLAC; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; NASOPHARYNGEAL NEOPLASMS; NEOPLASMS; OXIDATION-REDUCTION; SALICYLIC ACIDS; STRUCTURE-ACTIVITY RELATIONSHIP; SULINDAC; TETRADECANOYLPHORBOL ACETATE; TUMOR CELLS, CULTURED;

HUMAN HERPESVIRUS 4;

EID: 0034695162     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(00)00616-9     Document Type: Article

References (50)

1. Cancer chemoprevention
2. Cancer chemoprevention Part 1: Retinoids and carotenoids and other classic antioxidants
3. Cancer chemoprevention Part 11: Hormones, nonclassic antioxidant natural agents, NSAIDs and other agents
4. Chemopreventive drug development: Prospects and progress
5. Chemoprevention of cancer
6. The role of nonsteroidal anti- inflammatory drugs, eicosanoids, and colorectal cancer prevention
7. Nonsteroidal anti-inflammatory drugs, eicosanoids, and colorectal cancer prevention
8. Overview of articles on eicosanoids and cancer
9. Self-promotion? Intimate connections between APC and prostaglandin H synthase-2
10. Eicosanoids and the gastrointestinal tract
11. Piroxicam and other cyclooxygenase inhibitors: Potential for cancer chemoprevention
12. Prostaglandins, their inhibitors and cancer
13. Transcriptional regulation of cyclooxygenase-2 gene expression: Novel effects of nonsteroidal anti-inflammatory drugs
14. Chemoprevention of intestinal adenomas in the Apc(Min) mouse by piroxicam: Kinetics, strain effects and resistance to chemosuppression
15. Inhibitory effects of dihydroagarofuran sesquiterpenes on Epstein-Barr virus activation
16. Anti-tumor promoting effects of naphthoquinone derivatives on short term Epstein-Barr early antigen activation assay and in mouse skin carcinogenesis
17. Multistage carcinogenesis in mouse skin
18. Chemoprevention of colorectal cancer
19. A short-term in vitro assay for promoter substances using human lymphoblastoid cells latently infected with Epstein-Barr virus
20. Studies on inhibitors of skin tumor promotion: Inhibitory effects of triterpenes from Chlosperum tinctorium on Epstein-Barr virus activation
21. Eicosanoids and multistage carcinogenesis in NMRI mouse skin: Role of prostaglandins E and F in conversion (First stage of promotion) and promotion (second stage of tumor promotion)
22. Inverse association of prostate cancer and non- steroidal anti-inflammatory drugs (NSAIDs): Results of a case-control study
23. Inhibitory effect of curcumin and some related dietary compounds on tumor promotion and arachidonic acid metabolism in mouse skin
24. Endogenous 12(S)-HETE production by tumor cells and its role in metastasis
25. Inhibition of 5-hydroxyeicosatetraenoic acid (5-HETE) formation in intact human neutrophils by naturally occurring diarylheptanoids: Inhibitory activities of curcuminoids and yakuchinones
26. Curcumin: A potent inhibitor of leukotriene B4 formation in rat peritoneal polymorphonuclear neutrophils (PMNL)
27. Selective preservation of protein kinase C-zeta in the chemoprevention of azoxymethane-induced colonic tumors by piroxicam
28. Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: Growth inhibition by nonsteroidal anti-inflammatory drugs
29. The effect of NSAIDs and a COX-2 specific inhibitor on Helicobacter pylori-induced PGE2 and HGF in human gastric fibroblasts
30. Inhibitory effects of curcumin on protein kinase C activity induced by 12-O-tetradecanoyl-phorbol-13-acetate in NIH 3T3 cells
31. Aspirin, but not sodium salicylate, indomethacin, or nabumetone, reversibly suppresses 1,2-dimethylhydrazine-induced colonic aberrant crypt foci in rats
32. Chemoprotective effects of capsaicin and diallyl sulfide against mutagenesis or tumorigenesis by vinyl carbamate and N-nitrosodimethylamine
33. Influence of a prostaglandin synthesis inhibitor and of thrombocytopenia on tumor blood flow and tumor vascular permeability. Experimental studies in the rat
34. Protective role of aqueous turmeric extract against mutagenicity of direct-acting carcinogens as well as benzo(a)pyrene- induced genotoxicity and carcinogenecity
35. Sodium salicylate inhibits macrophage TNF-alpha production and alters MAPK activation
36. Modulation of azoxymethane-induced mutational activation of ras protooncogenes by chemopreventive agents in colon carcinogenesis
37. Effect of etodolac on prostaglandin E2 biosynthesis, active oxygen generation and bradykinin formation
38. Sulindac inhibits activation of the NF-kB pathway
39. The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta
40. Sulindac inhibits activation of the NF-kappaB pathway
41. Curcumin inhibits cell proliferation by interfering with cell cycle and including apoptosis in colon carcinoma cells
42. Prevention of colon cancer and modulation of aberrant crypt foci, cell proliferation, and apoptosis by retinoids and NSAIDs
43. Modulation of apoptosis by sulindac, curcumin, phenylethyl-3lmethylcaffeate, and 6-phenylhexyl isothiocyanate: Apoptotic index as a biomarker in colon cancer chemoprevention and promotion
44. Probing the molecular program of apoptosis by cancer chemopreventive agents
45. Reactive oxygen species are involved in the apoptosis induced by nonsteroidal anti-inflammatory drugs in cultured gastric cells
46. Mesalazine changes apoptosis and proliferation in normal mucosa of patients with sporadic polyps of the large bowel
47. Properties of intraepithelial neoplasia relevant to the development of cancer chemopreventive agents
48. Diet intervention for modifying cancer risk
49. Nonsteroidal antiinflammatory agents in chemoprevention of colorectal cancer At what cost?
50. Clinical uses of etodolac for the treatment of lumbar disc herniation